Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-03-25

FDA Approved: SILDENAFIL CITRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for sildenafil citrate by Mylan Pharmaceuticals, updating the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sildenafil citrate (Sildenafil citrate)

Snippet

SUPPL AP for SILDENAFIL CITRATE (SILDENAFIL CITRATE)